Objectives: The purpose of this study was to compare the costs of traditional laparoscopy and robotic-assisted laparoscopy in the treatment of endometrial cancer. Methods and Materials: A total of 101 patients with endometrial cancer were randomized to the study and operated on starting from 2010 until 2013, at the Department of Obstetrics and Gynecology of Tampere University Hospital, Tampere, Finland. Costs were calculated based on internal accounting, hospital database, and purchase prices and were compared using intention-to-treat analysis. Main outcome measures were item costs and total costs related to the operation, including a 6-month postoperative follow-up. Results: The total costs including late complications were 2160 € higher in the robotic group (median for traditional 5823 €, vs robot median 7983 €, P G 0.001). The difference was due to higher costs for instruments and equipment as well as to more expensive operating room and postanesthesia care unit time. Traditional laparoscopy involved higher costs for operation personnel, general costs, medication used in the operation, and surgeon, although these costs were not substantial. There was no significant difference in in-patient stay, laboratory, radiology, blood products, or costs related to complications. Conclusions: According to this study, robotic-assisted laparoscopy is 37% more expensive than traditional laparoscopy in the treatment of endometrial cancer. The cost difference is mainly explained by amortization of the robot and its instrumentation.
traditional laparoscopy and robotic-assisted laparoscopy (total costs without equipment: USD 24,433, USD 20,289, and USD 20,467, respectively). The robot platform has been in use at Tampere University Hospital since 2009, and the robot is used by urologists, gynecologists, and thoracic surgeons, with an annual rate of 345 to 400 operations.
The aim of this analysis was to compare the costs of conventional laparoscopy and robotic-assisted laparoscopy in the treatment of endometrial cancer, to evaluate possible differences and identify factors influencing the costs within a randomized trial.
MATERIALS AND METHODS
In a clinical trial, 101 patients presenting with endometrial cancer were randomized into 2 arms, traditional laparoscopy (traditional, n = 51) and robotic-assisted laparoscopy (robot, n = 50). Inclusion criteria were a low-grade (Grade 1Y2) endometrial cancer, a scheduled staging operation, and a signed informed consent. Exclusion criteria included a narrow vagina or a uterus too large to be removed through the vagina and ineligibility for a deep Trendelenburg position. The details of the study population, randomization procedure, and operations have been described in detail previously. 4 The operations were performed at a tertiary referral center, the Department of Obstetrics and Gynecology of Tampere University Hospital, Tampere, Finland from 2010 to 2013 by gynecologic oncologists with several years of experience with laparoscopic surgery. The study protocol was approved by the Research Ethics Committee of Tampere University Hospital (identification code ETL R10081) and is registered at www.clinicaltrials.gov (NCT 01466777). The costs were calculated retrospectively in euros. The cost variables are presented in Table 1 .
The patient data were collected from the operation and onwards over the subsequent follow-up period of 6 months. All contacts and procedures at follow-up hospitals (imaging studies, readmissions, operative treatment) were recorded. These contacts and the costs related to them were calculated in complications and are referred in this article also as late complications. In complication costs, all expenses related to the contact have been taken into account. This includes also all out-patient visits, which led or did not lead to any procedures. Patients contacted clinics for various reasons such as swelling, bruises, and vaginal bleeding among other complaints. Most of these were normal postoperative symptoms. Because of swelling in lower extremities, many patients underwent a Doppler ultrasound imaging to exclude deep venous thrombosis with no findings. 4 Public health care in Finland uses an internal accounting and billing system within the hospitals. Different hospital units offer services based on their expertise such as anesthetic services, operating room (OR) services, laboratory services, and consultations provided by other specialties like urologic surgery. We searched the hospital databases to retrieve the actual costs of each operation.
The original expense data from 2012 was used as the basis for calculating costs for operation personnel, amortization of the laparoscopy towers and the robot console, OR costs, medication during the operation, and general costs related to the hospital infrastructure. The 2012 expense data was chosen because it represents the midpoint of the study period.
The amortization and use of an energy instrument in traditional laparoscopy group was also included in the instrument costs; an energy instrument was used in 15 operations, based on the operating surgeon's judgment.
Costs related to the instrumentation, in-patient stay, radiology, and laboratory services as well as blood products were calculated or retrieved from the database according to the actual time (exact date or at least year) of the operation. Inpatient stay, radiology, laboratory, and blood product expenses were retrieved from the internal accounting system. For disposable instruments and products, we used the real hospital purchase costs, according to the reported data on each operation, and we included in every operation a basic array of instruments and equipment involved in the operative set-up. Traditional and robotic operations had a different basic package based on the needs of the operative method. For reusable instruments, the maintenance costs were calculated. For robot instruments, the cost of amortizing (maximum 10 operations per instrument), and the maintenance costs were taken into account.
The robot at Tampere University Hospital is the Da Vinci S surgical system (Intuitive Surgical, Inc, Sunnyvale, Calif ). It is a leased product with a 10-year contract. The annual leasing and maintenance costs are 196,000 € and 140,000 €, respectively. We divided these costs with the total number of operations during the year 2012 to calculate the robot platform amortization cost per robot operation.
One patient was originally randomized into the traditional laparoscopy group, but the surgeon decided to change the operative procedure to robotic-assisted laparoscopy because of the obesity of the patient. Because of this randomization violation, secondary analyses were performed besides the primary intention-to-treat analysis, which is a per protocol analysis with groups based on the actual operative manner (this patient was included in the robot arm), and also excluding this patient.
Two patients from the traditional laparoscopy group who were not suitable for laparoscopic operation were operated through laparotomy, and their data was not analyzed in the study. 4 Consequently, the final number of patients in the analysis was 49 in the traditional group and 50 in the roboticassisted group.
Distributions of cost factors were shown by medians with interquartile ranges due to the skewed distributions and outliers. Differences between traditional and robotic-assisted laparoscopic surgical costs were analyzed by nonparametric independentsamples Mann-Whitney U test. 
RESULTS
Because there were no substantial differences in the results of the intention-to-treat and treatment received analyses, only the results of the intention-to-treat analysis are presented here. Results using the secondary analyses are given in the Supplemental Tables (S1 to S4 http://links.lww.com/IGC/ A545).
The item costs were higher in the robotic-assisted laparoscopy arm for instruments, equipment, and OR, as well as postanesthesia care unit (PACU) ( Table 2 ). Traditional laparoscopy had higher costs for operation personnel and medication, general costs and surgeon costs, but these differences were relatively small (Table 1 for variable definitions, Table 2 ). There were no significant differences in costs related to in-patient stay, laboratory and radiology services, or blood products. The median total costs for the robotic-assisted laparoscopy, including late complications were 2160 € higher than for traditional laparoscopy (1.4-fold, cost per operation: 7982 € vs 5823 €, respectively; Fig. 1 ).
There were 5 conversions to laparotomy in the traditional laparoscopy group and none in the robot group. 4 The total costs without late complications for these patients were substantially higher than for the rest of the traditional laparoscopy patients (nonconversions Md 5352 € vs conversions 7149 €, P G 0.001) There was also a significant difference in the length of in-patient stay (Md 1 vs 4 days, P G0.001), which increased the costs of the in-patient stay (1114 € vs 2148 €, P = 0.002). Moreover, there was a significant difference in PACU time (Md 2 hours and 22 minutes vs 3 hours 33 minutes, P G 0.001), which also affected the PACU costs (704 € vs 938 €, P G 0.001). The median total costs related to the laparoscopy-laparotomy converted operations are close to the median total cost of the robot arm without complications (7415 €).
Ten patients in the traditional group and 20 patients in the robot group contacted the follow-up hospitals or had complications reported. The related median costs were 766 € and 844 € per patient, respectively (P = 0.530).
The operative time as well as the OR time were significantly shorter in the robot group, whereas PACU time was shorter in the traditional group (Table 3) . 4 Although there was no significant difference in the median length of postoperative in-patient stay (Table 3 ), 1 patient in the traditional group was not discharged until postoperative day 7. Physically, the patient's recovery from the surgery did not differ from that of other patients, but the patient's mental status did not allow discharge, and she was waiting for a transfer to a municipal hospital. This created an outlier in the in-patient stay costs (3343 €). We were unable to calculate the costs of the following municipal hospital stay.
One patient in the robot group underwent embolization while she was in the PACU because of a bleeding complication. This patient stayed in the PACU for 16 hours and 2 minutes causing an outlier in the PACU time and PACU costs (4492 €), as well as the embolization cost in the Radiology Department (2884 €). We included the costs (embolization, laboratory, radiology, PACU) in this patient's primary operation period, not itemizing them stratified according to the complications, because it was difficult to reliably differentiate the costs of this complication from the costs of the surgery itself, for example, in the PACU costs. One patient in the robot group needed 2 reoperations because of a rectovaginal-fistula. This patient also had repeated imaging studies and readmissions because of the complication. These costs created an outlier in complication costs (14,818 €) .
No postoperative deaths occurred during the study period nor were there any thromboembolic events during the follow-up. 4 There was no significant difference between the 2 arms in duration of sick leave (Table 3) . Most of the patients did not receive sick leave because they were already retired. Consequently, sick leave costs were not calculated in this analysis.
Robot instrument cost per operation was 1030 € (including 4 basic instruments used in the operations), and the amortization cost of the robot console per operation was 939 € according to the 2012 expense data (taken into account in equipment and OR costs). On this basis, we calculated costs per duration of OR timeYrelated amortization cost (5.95 € per minute) and applied it individually for each operation in accordance with the operating time. Therefore, the equipment and OR costs for some patients can be less than 939 € (range, 844 €Y1503 €).
CONCLUSIONS
The median actual costs of the robotic-assisted laparoscopy were 1928 € (35%) higher per patient than the costs related to traditional laparoscopy. Although direct international comparisons are difficult to make because of differences in national health care funding systems, our results seem to be comparable with findings in previous studies, showing robotic-assisted laparoscopy to be 17% to 33% more expensive. 5, 6 Amortization of the robot console and costs involved with robot instrumentation are the major determinants of the incremental costs related to robotic-assisted surgery.
5Y9 Amortization can be minimized by increasing the number of operations. However, because a set of robot instruments can only be used in 10 operations, the instrument costs are practically fixed. Although we have previously shown that the operation time is shorter in robotic-assisted than traditional laparoscopic operations, 4 the shorter operation time was not enough to balance out the costs of amortization of the robot console and the use of robot instruments.
In Finland, doctors and surgeons in the public health care receive a monthly salary instead of fee for service. This explains the lower labor cost of surgeon per operation compared with a previous US study. 3 In our study, the surgeon cost is related only to the duration of the operation.
The major strength of this study is the randomized design, ensuring an unbiased comparison between the treatment arms. The learning curve effect was also minimized as robotic surgery for gynecologic indications was started at our hospital already in March 2009. We have previously shown that the learning curve for robotic surgery is relatively short or 10 operations. 10 Moreover, our experience with laparoscopic surgery for endometrial cancer dates from 1990s. 11 Both operative techniques were therefore already well-established at the time the randomized trial was initiated.
The 2 groups were well balanced in relation to all major patient characters. 4 The costs were calculated in a detailed fashion for each operation based on actual cost items, including even from the surgeons' gloves and threads used.
During the time of the study design, the standard surgical treatment of endometrial cancer at our institution was hysterectomy, bilateral salpingo-oophorectomy, and in most cases, pelvic lymphadenectomy (PLND). These 3 procedures were scheduled to be performed to all of the randomized patients. However, PLND was not performed on 2 patients in both arms (total n = 4) because of a disseminated disease. 4 The costs of PALND were not evaluated. Current guidelines encourage PALND, besides PLND, to be performed in patients with high-risk endometrial cancer, whereas in the case of low-risk cancer, only hysterectomy and bilateral salpingo-oophorectomy without LND should be performed. 12 Because extending the lymphadenectomy to the para-aortic area makes traditional laparoscopy challenging to perform the cost difference might have been smaller if PALND were included in the randomized study design. 13 Although the number of patients was rather limited, the outliers encountered in some variables did not substantially affect the final results. There are some local factors that inevitably constrain the generalizability of the results. Our robot console and its PACU are located in a separate building apart from the Department of Obstetrics and Gynecology and its ORs. This increases the expenses because of additional PACU time.
Quality of life was not investigated in this study, which can be considered a limitation.
Laparoscopic approach has replaced laparotomy in the operative treatment for endometrial cancer. 12 At present, laparotomy should not be considered as the primary operation method anymore now that minimally invasive methods have been evolved. 13, 14 Moreover, according to a recent study comparing the costs of robotic-assisted laparoscopic hysterectomy to open hysterectomy, laparotomy was more expensive, mainly because of longer in-patient stay. 15 In the field of laparoscopy, the robotic-assisted technique has introduced many advantages such as diminished blood loss, wristed instruments, 3-dimensional stereoscopic vision, better ergonomics for surgeon, and a shorter learning curve. 9Y11,16,17 This was reflected also in the present study, where no conversions to laparotomy had to be undertaken in the robot group as opposed to 5 conversions in the traditional group. The total costs of the converted operations were almost as high as the costs of the robotic-assisted operations (Md 7149 € vs 7415 €, respectively).
In contrast to clinical operations performed for real patients, in which setting each robotic instrument can be used only 10 times, in the preclinical training phase, the same instruments can be used 30 times (data obtained during from robotic training at Tampere University Hospital, Da Vinci S surgical system; Intuitive Surgical, Inc, Sunnyvale, Calif ). If robotic instruments could also clinically be used 30 times, it would decrease the instrument costs by 688 €. On the other hand, if the annual number of gynecological operations at our institution would be increased from 84 to 120, with 3 instead of 2 daily operation, the amortization costs would decrease by 282 € per operation. By such means, the median total costs for robotic surgery would be 6445 €, and the difference between the 2 operation types would decrease to 17%.
We were unable to assess patient outcomes in terms of quality-adjusted life year (QALY) (because no obvious difference in complications or other patient outcomes were found), so real cost-effectiveness analysis was not possible. However, applying a cost-effectiveness threshold of 50,000 €; per QALY to the observed cost difference of 2160 € per operation, it would mean that 1 QALY would need to be gained per 26 patients operated to reach the threshold.
The robotic-assisted technique in the staging of endometrial carcinoma (hysterectomy, bilateral salpingooophorectomy, and PLND) increases the total treatment costs by one third compared with the traditional technique. In our setting, this translates into roughly 2000 € per patient. For further research, it would be beneficial to calculate the costs in similar form including the PALND.
